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Abstract
Background:  The association between the human cytotoxic T lymphocyte-associated antigen-4
(CTLA4) gene and insulin-dependent diabetes mellitus (IDDM) is unclear in populations. We
therefore investigated whether the gene conferred susceptibility to IDDM in a Russian population.
We studied two polymorphic regions of the CTLA4 gene, the codon 17 dimorphism and the (AT)n
microsatellite marker in the 3' untranslated region in 56 discordant sibling pairs and in 33 identical
by descent (IBD) affected sibships.
Results:  The Alal7 allele of the CTLA4 gene was preferentially transmitted from parents to
diabetic offspring (p<0.0001) as shown by the combined transmission/disequlibrium test (TDT) and
sib TDT (S-TDT) analysis. A significant difference between diabetic and non-diabetic offspring was
also observed for the transmission of alleles 17, 20, and 26 of the dinucleotide microsatellite. Allele
17  was transmitted significantly more frequently  to  affected  offspring than  to  other children
(p=0.0112) whereas alleles 20 and 26 were transmitted preferentially to non-diabetic sibs (p=0.045
and 0.00068 respectively). A nonrandom excess of the Ala17 CTLA4 molecular variant (maximum
logarithm of odds score (MLS) of 3.26) and allele 17 of the dinucleotide marker (MLS=3.14) was
observed in IBD-affected sibling pairs.
Conclusion:  The CTLA4 gene is strongly associated with, and linked to IDDM in a Russian
population.
Introduction
The cytotoxic T lymphocyte-associated antigen 4 gene
(CTLA4) encodes the T cell receptor involved in the con-
trol of T cell proliferation and mediates T cell apoptosis
[1]. The receptor protein is a specific T lymphocyte sur-
face antigen that is detected on cells only after antigen
presentation. Thus, CTLA4 is directly involved in both
immune and autoimmune responses and may be in-
volved in the pathogenesis of multiple T cell-mediated
autoimmune disorders.
The human CTLA4 gene was mapped to chromosome
2q33 [2]. It consists of three exons. The first encodes a V-
like domain of 116 amino acids. An A-to-G substitution at
nucleotide 49 in exon 1 results in an amino acid substitu-
tion (Thr/Ala) in the leader peptide of the protein [3].
The Ala allele has been shown to predispose the individ-
ual carrying it to the development of various immune
diseases including Graves' disease [3, 4], Hashimoto's
thyroiditis [5], Addison's disease [5], rheumatoid arthri-
tis [6,7], celiac disease [8,9], and others [10].
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The Thr17Ala dimorphism and the polymorphic (AT)n
microsatellite starting at position 642 of the 3' untrans-
lated region flanking exon 4 of the CTLA4 gene and lo-
cated 5.3 kb 3' of the biallelic codon 17 were shown to be
linked to, and associated with, insulin-dependent diabe-
tes mellitus (IDDM) in Italian diabetic families [11]. This
led Nistico et al. [11] to refer to the susceptibility to dia-
betes associated with CTLA4 as IDDM 12. Further evi-
dence for an IDDM susceptibility locus on chromosome
2 in 2q33, the region containing the CTLA4 gene, has
been provided from various ethnic groups including
Caucasians (British, Spanish, French, Swedish, and Bel-
gian), Mexican-Americans, and Asians (Korean, Chi-
nese, Japanese) [3, 121314151617]. In contrast, a lack of
association of the CTLA4 gene with IDDM was observed
in other Caucasian populations including Sardinians
[12], Germans [18], Danish [19], and U.S. whites [20].
We therefore decided to investigate whether this gene
conferred susceptibility to IDDM in a Russian popula-
tion. We carried out family studies using two polymor-
phic markers at the CTLA4 gene locus: codon 17
dimorphism and the dinucleotide microsatellite in the 3'
untranslated region.
Results
We observed preferential transmission of the Ala allele of
the CTLA4 gene from parents to diabetic offspring (Table
1). The observed difference in transmission was highly
significant, as shown by the transmission disequilibrium
test (TDT) and combined TDT and sib TDT (S-TDT)
analysis (p<0.0001).
For another polymorphic marker of the CTLA4 gene, the
dinucleotide microsatellite, we detected 17 alleles from
92 to 130 bp in length. Alleles were designated according
to the number of repeat units. For instance, the smallest
allele contained 11 AT repeats and was referred to as al-
lele 11. A significant difference between diabetic and
non-diabetic offspring was observed for the transmis-
sion of three alleles numbers 17, 20, and 26, in combined
TDT and S-TDT analysis (Table 2). Allele 17 was trans-
mitted significantly more frequently to affected than to
unaffected sibs (P=0.0112) whereas alleles 20 and 26
were preferentially transmitted to non-diabetic sibs
(P=0.045 and 0.00068).
We assessed the linkage to IDDM of both polymorphic
markers of the CTLA4 gene in affected sibling pairs
(ASPs), identical by descent (IBD), by assessing the sig-
nificance of the deviation of the observed IBD allele dis-
tribution from a random distribution (Table 3). A
nonrandom excess of the Ala17 allele was observed in
IDDM ASPs (Χ 2=24.892, df=2, p=0.000015), with a log-
arithm of odds (LOD) score of 3.54. After correction for
the number of alleles at this marker (2), our maximum
LOD score (MLS) was reduced to 3.24 (Table 3). For the
dinucleotide microsatellite, a MLS of 4.37 was obtained
for the allele 17. Correction for the number of observed
alleles (17) decreased the value to 3.17. Allele 17 dis-
played a distribution in APSs differed significantly from
a random distribution (Χ 2=64.884, df=2, p<0.000001).
Discussion and conclusion
TDT and S-TDT analyses revealed that both markers
within the CTLA4 gene were significantly associated with
IDDM in a Russian population. Both TDT and combined
tests showed a clear association of the Thr17Ala dimor-
phism in the gene (Table 1). For the second polymorphic
marker tested, the dinucleotide microsatellite, a signifi-
cant difference in the transmission of the three alleles
was observed, even after correction for multiple alleles
(Table 2). This suggests that the (AT)n repeat polymor-
phism of the CTLA4 gene is associated with IDDM in this
Russian population.
Table 1: Transmission of alleles of the codon 17 dimorphism at the CTLA4 locus from heterozygous parents to affected probands in 56 
discordant sibling pairs with IDDM
Allele TDT Combined (TDT + S-TDT)
Transmitted Not Χ 2a PZ 'P
transmitted (df=1) value Value
Ala 39 11 15.680 0.00008 4.072 0.00003
Thr11 39 15.680 0.00008 4.072 0.00003BMC Genetics (2001) 2:6 http://www.biomedcentral.com/1471-2156/2/6
Transmission disequilibrium analysis in discordant sib-
ling pairs showed that the Ala17 variant of the CTLA4
gene and allele 17 at the intragenic dinucleotide micros-
atellite were associated with a high risk of IDDM. The
maximum LOD scores were also sufficient to indicate
that the CTLA-4 region of chromosome 2q33 is linked to,
and associated with, IDDM in a Russian population.
Thus, our findings are consistent with those of earlier
family studies showing a positive association between
the CTLA4 gene and IDDM in most populations tested
and role of the Ala17 allele is predisposing the individual
to the disorder [3, 11121314151617]. Linkage analysis
with a CTLA4 dinucleotide marker in 48 Italian IDDM
families gave a MLS of 3.22 which is consistent with our
results [11]. Our findings suggest that allele 17 is a com-
mon 'predisposition' allele of the dinucleotide marker.
Our data are consistent with those of Marron et al. [12]
who reported a significantly higher frequency of allele 17
to affected siblings in pooled diabetic pedigrees from
multiple ethnic groups than of other alleles of the dinu-
cleotide marker. Allele 17 was in strong linkage disequi-
librium with the Ala allele in the Russian population and
in other populations tested (data not shown) [12].
The CTLA4 gene (IDDM12) is located in the vicinity of
two other IDDM susceptibility regions, IDDM7 (2q31)
[21] and IDDM13 (2q34) [22], and the genes encoding
CD28, IA-2 and islet tyrosine phosphatase, which may be
considered to be candidate IDDM susceptibility genes
[23]. This closeness to other IDDM susceptibility regions
and putative susceptibility genes may account for the
weakness or absence of association of the CTLA4 gene
with IDDM in some populations.
A functional significance of the CTLA4 codon 17 dimor-
phism is unknown. The amino acid substitution thought
unlikely to affect the function of the CTLA-4 molecule.
The CTLA4 microsatellite (AT)n repeat may affect RNA
stability, for the AT-rich sequences in 3' untranslated re-
gions of mRNA molecules for example [24, 25]. Linkage
between the two CTLA4 polymorphic markers has been
shown [26]. This may indirectly affect CTLA4 signal
transduction or intracellular sorting [27]. The Ala17 al-
lele is probably correlated with rapid-onset insulin defi-
ciency, and functional studies with Ala/Ala homozygous
patients may elucidate the functional significance of co-
don 17 dimorphism in T-cell regulation [28].
Table 2: Transmission of alleles of the (AT)n polymorphic marker at the CTLA4 locus from heterozygous parents to affected probands 
in 56 discordant sibling pairs with IDDM
Allele TDT Combined (TDT+S-TDT)
length, Transmitted Not Χ 2a PZ ' a P
bp transmitted value Value
11 0 2
12 1 1
13 4 9
14 1 0
15 9 5
16 14 9
17 21 4 11.560 0.0112 3.200 0.00112
18 7 2
19 1 2
20 2 14 9.000 0.0405 2.750 0.045
21 12 4
24 9 10
25 2 1
26 2 21 15.696 0.0017 3.956 0.00068
27 0 1
29 1 1
30 1 1
a Only Χ 2 (df=1) and z' values for which P<0.05 are indicatedBMC Genetics (2001) 2:6 http://www.biomedcentral.com/1471-2156/2/6
CTLA4 is known to be involved in the fine tuning of the
immune response, the disruption of which may result in
autoimmunity. Recent animal model-based studies have
shown that CTLA4Ig injection can prevent relapse of the
autoimmune process in BB rats [28]. This suggests that
CTLA4 may be a suitable target for the specific preven-
tion of β -cell autoimmunity [27].
Our data, showing the linkage and association of the
CTLA4 gene with IDDM, together with many other pop-
ulation-based fundings, suggest that the chromosome
2q33 region (IDDM12) is a true IDDM susceptibility lo-
cus. The CTLA4 region may function as a common locus
for HLA genes and genes conferring susceptibility to au-
toimmunity in general. A number of findings, including
our studies of association between CTLA4 codon 17 and
Graves' disease [29], support this view.
Materials and methods
Subjects
Fifty-six Russian families, each consisting of two siblings
(one affected with IDDM diagnosed before the age of 18
years and one non-diabetic sibling) were studied. Sixteen
families were recruited from the Samara Diabetic Center,
the other families being recruited from the Endocrino-
logical Research Center in Moscow. Thirty-three nuclear
diabetic families, recruited from the Endocrinological
Research Center and consisting of two unaffected par-
ents and two sibs with IDDM, were also analysed.
DNA typing
Human DNA was extracted from whole blood using a
phenol-chloroform technique [30]. A polymerase chain
reaction-restriction fragment length polymorphism
(PCR-RFLP) assay was used to detect Thr17Ala dimor-
phism as described by Donner et al. [3]. The dinucleotide
repeat polymorphism was studied by PCR, as described
by Polymeropoulos et al. [31]. DNA fragments were sep-
arated by electrophoresis in 12% polyacrylamide gels and
stained with silver nitrate [32].
Statistical analysis
We carried out linkage disequilibrium analysis in dis-
cordant sibling pairs by combined TDT and S-TDT anal-
ysis [33, 34]. For TDT, we estimated the significance of
deviations from a random pattern of allele transmission
was estimated using the Χ 2 test. For both S-TDT and the
combined test, a z score was calculated for each allele. A
nominal P value of less than 0.05 after correction for
multiple alleles was considered significant.
Linkage between polymorphic markers and susceptibili-
ty to IDDM was assessed in APSs by assessment of the
extent to which the observed distribution of shared alle-
les, identical by descent, differed from a random distri-
bution (1:2:1 for sharing of 2, 1, and 0 alleles would be
expected). Parents homozygous for an allele were con-
sidered to be genetically uninformative. Χ 2 was calculat-
ed using Roff & Bentzen's algorithm [35] to determine
the significance of the degree of excess allele sharing by
ASPs. The logarithm of odds score was calculated as de-
scribed by Risch [36] using correction for the number of
alleles tested [37]. A LOD score of 3.0 or more was con-
sidered to indicate significant linkage.
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